GlassScriptPhysician profile
Adam Denker
NPI 1205013463
$3,291.13
in general payments reported to CMS, 2019-2025
25 companies · $353 in 2025
The $353 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $352 · 2020: $284 · 2021: $364 · 2022: $650 · 2023: $841 · 2024: $447 · 2025: $353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,641.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,640.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,050.65 | 2019-2025 | Watchman Flx, Watchman Access System, Lux-Dx Insertable Cardiac Monitor |
| Biosense Webster, INC. | $561.50 | 2022-2025 | Carto 3, Nuvision Ice Catheter |
| Medtronic, INC. | $241.21 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $230.28 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $216.90 | 2019-2022 | |
| Abbott Laboratories | $174.73 | 2019-2025 | Jot Dx |
| Medtronic Vascular, INC. | $124.99 | 2019 | |
| Sanofi-Aventis U.S. LLC | $93.06 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $91.06 | 2019-2023 | |
| Irhythm Technologies, INC. | $68.61 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Daiichi Sankyo INC. | $68.30 | 2023 | Injectafer |
| Merck Sharp & Dohme LLC | $67.28 | 2022 | |
| Cvrx, INC. | $65.19 | 2023-2025 | Barostim Neo System |
| Pfizer INC. | $28.34 | 2021-2022 | |
| Atricure, INC. | $27.15 | 2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.25 | 2023 | Jardiance |
| Lexicon Pharmaceuticals, INC. | $21.64 | 2024 | |
| Alnylam Pharmaceuticals INC. | $20.60 | 2022 | |
| Novo Nordisk INC | $19.58 | 2022 | |
| Cordis US Corp. | $19.22 | 2025 | Mynx Control Venous |
| E.R. Squibb & Sons, L.L.C. | $18.68 | 2025 | Eliquis |
| Azurity Pharmaceuticals, INC. | $16.97 | 2023 | Edarbi |
| Bayer Healthcare Pharmaceuticals INC. | $16.36 | 2021 | |
| Alexion Pharmaceuticals, INC. | $15.95 | 2021 | |
| Althera Pharmaceuticals LLC | $10.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Denker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.